BOBULSKY SUSAN has filed 12 insider transactions across 1 company since March 2024.
Most recent transaction: a sale of 41338 shares of Adaptive Biotechnologies Corp ($ADPT) on March 11, 2026.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S | Common Stock | 41338 | $13.17 | 427,775.0000 | 163,162,107 | 8.81% | 0.03% |
| March 4, 2026 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Common Stock | 62500 | $0.00 | 469,113.0000 | 163,162,107 | 15.37% | 0.04% |
| March 4, 2026 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Common Stock | 59375 | $0.00 | 406,613.0000 | 163,162,107 | 17.10% | 0.04% |
| March 4, 2025 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Common Stock | 119971 | $0.00 | 373,261.0000 | 147,101,648 | 47.37% | 0.08% |
| March 5, 2025 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S | Common Stock | 26023 | $6.98 | 347,238.0000 | 147,101,648 | 6.97% | 0.02% |
| March 4, 2025 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Stock Option (right to buy) | 180029 | $0.00 | 180,029.0000 | 147,101,648 | 9999.99% | 0.12% |
| Oct. 8, 2024 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | M | Stock Option (right to buy) | 5000 | $0.00 | 0.0000 | 147,516,398 | 100.00% | 0.00% |
| Oct. 8, 2024 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | M | Common Stock | 5000 | $1.98 | 253,290.0000 | 147,516,398 | 2.01% | 0.00% |
| March 5, 2024 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S | Common Stock | 6016 | $3.43 | 255,265.0000 | 144,383,294 | 2.30% | 0.00% |
| March 5, 2024 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S | Common Stock | 6975 | $3.44 | 248,290.0000 | 144,383,294 | 2.73% | 0.00% |
| March 4, 2024 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Stock Option (right to buy) | 199549 | $0.00 | 199,549.0000 | 144,383,294 | 9999.99% | 0.14% |
| March 4, 2024 | Adaptive Biotechnologies Corp | $ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | A | Common Stock | 132979 | $0.00 | 261,281.0000 | 144,383,294 | 103.65% | 0.09% |